Johns hopkins launches first home microdose psilocybin safety trial

This early-stage study at Johns Hopkins University is testing whether very small, repeated doses of psilocybin (the active ingredient in magic mushrooms) are safe for healthy people to take at home. Twenty volunteers will receive four different microdoses and a placebo on separate days in a double-blind design. Researchers will monitor blood pressure, heart rate, sobriety, and mental status to determine which doses could be safely used outside a clinic.